Results 271 to 280 of about 70,546 (390)

Unexpected Course of Reaction Between (1E,3E)-1,4-Dinitro-1,3-butadiene and N-Methyl Azomethine Ylide-A Comprehensive Experimental and Quantum-Chemical Study. [PDF]

Molecules
Sadowski M, Kula K.
europepmc   +1 more source

High‐Voltage Cathode Materials for Sodium‐Ion Batteries: Advances and Challenges

Small, EarlyView.
This review explores the role of high‐voltage cathode materials in enhancing the performance of SIBs. It focuses on strategies to improve energy density, rate capacity, and stability, addressing challenges like phase transitions, metal migration, and electrolyte degradation.
Congqi Ren, Yulian Dong, Yong Lei
wiley   +1 more source

Combining Photochemical Oxyfunctionalization and Enzymatic Catalysis for the Synthesis of Chiral Pyrrolidines and Azepanes. [PDF]

J Org Chem
Logotheti M, Gehres S, França AS, Bornscheuer UT, de Souza ROMA, Höhne M.   +5 more
europepmc   +1 more source

Studies on the Constituents of Broussonetia Species VIII. Four New Pyrrolidine Alkaloids, Broussonetines R, S, T, and V and a New Pyrroline Alkaloid, Broussonetine U, from Broussonetia kazinoki SIEB.

, 2001
Daisuke Tsukamoto, Makio Shibano, Rieko Okamoto, Genjiro Kusano   +3 more
openalex   +2 more sources

Structure–activity analysis of imino‐pyrimidinone‐fused pyrrolidines aids the development of dual plasmepsin V and plasmepsin X inhibitors

The FEBS Journal, EarlyView.
Compounds were identified that inhibit the aspartic protease plasmepsin V from Plasmodium vivax. Further development of these compounds identified compounds, such as S‐WM48, that could inhibit both plasmepsin V and plasmepsin X but plasmepsin IX was not significantly inhibited.
Anthony N. Hodder, Brad E. Sleebs, Greg Adams, Sina Rezazadeh, Anna Ngo, Kate Jarman, Stephen Scally, Peter Czabotar, Hongwu Wang, John A. McCauley, David B. Olsen, Alan F. Cowman   +11 more
wiley   +1 more source

Design and Synthesis of Potential Multi-Target Antidepressants: Exploration of 1-(4-(7-Azaindole)-3,6-dihydropyridin-1-yl)alkyl-3-(1H-indol-3-yl)pyrrolidine-2,5-dione Derivatives with Affinity for the Serotonin Transporter. [PDF]

Int J Mol Sci
Wróbel MZ, Chodkowski A, Siwek A, Satała G, Bojarski AJ, Dawidowski M.   +5 more
europepmc   +1 more source

Diastereoselective Iodoamidation of 3-Acetoxybut-1-enylamines: Synthesis of 3-Acetoxy-4-iodo-2-(p-methoxybenzyl)pyrrolidines

, 2001
Woo Song Lee, Kyu‐Tae Chang, Ki Chang Jang, Ho-Yong Park, Young Kook Kim, Ki Hun Park   +5 more
openalex   +1 more source

Discovery of Novel Pyrrolidine-Based Chalcones as Dual Inhibitors of α-Amylase and α-Glucosidase: Synthesis, Molecular Docking, ADMET Profiles, and Pharmacological Screening. [PDF]

ACS Omega
Kurşun Aktar BS, Sıcak Y, Bakırdöven A, Yılmaz GT, Yılmaz Ö, Karaküçük-İyidoğan A, Taşdemir D, Sağlam E, Oruç-Emre EE.   +8 more
europepmc   +1 more source

Practical Synthesis of a 1.BETA.-Methylcarbapenem, J-111,225, Using 4-Mercapto-2-[4-(N-methylaminomethyl)phenyl] pyrrolidine as a Precursor.

, 2001
Hideaki Imamura, Aya Shimizu, Hiroki Sato, Yuichi Sugimoto, Shunji Sakuraba, Koji Yamada, Hajime Morishima   +6 more
openalex   +2 more sources

Dual ETA‐ETB receptor antagonism improves metabolic syndrome‐induced heart failure with preserved ejection fraction

Fundamental &Clinical Pharmacology, Volume 39, Issue 3, June 2025.
Abstract Background Metabolic syndrome (MetS) is a multifaceted disease associated with heart failure (HF), which affects the vascular system. The endothelin (ET) system is a key player in MetS and HF; therefore, targets for ET receptors are of therapeutic interest.
Francesca Lockwood, Marianne Lachaux, Najah Harouki, Matthieu Soulié, Lionel Nicol, Sylvanie Renet, Anaïs Dumesnil, Magali Vercauteren, Jeremy Bellien, Marc Iglarz, Vincent Richard, Paul Mulder   +11 more
wiley   +1 more source